ArticleBlood advances2026
Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL.
Sung K Chiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it